Tasly North America
Tasly North America is dedicated to a healthier world. In this mission, we are actively pursuing a global commercialization strategy. Our methodology is very collaborative in nature. We seek strategic partnerships with other pharmaceutical companies, natural product producers, universities, hospitals and researchers and developers in the fields of Pharmaceuticals, Biologics, Nutraceuticals and Biopharmaceuticals.
Our strategy also includes acquisition, licensing, and Events Costumes commercialization of pharmaceutical products and technologies. To this end, we welcome inquiries regarding investment opportunities, Joint Ventures and development funding. Help us in our quest to bring the joy of health to all and perhaps we can prove of help to achieve your organization’s goal as well.
Tasly U.S. is the overseas headquarters of Tasly Pharmaceuticals Group, Co. Ltd., a China-based corporation trading publicly on the Shanghai exchange (SHA:600535). Tasly is an A-Share listed company with the current market capitalization of US $8 Billion.